Jun Qin, Ph.D.
Staff, Professor of Molecular Medicine
The Bonnie and Eunice Collins Endowed Chair for Innovative Diabetes Research
Lerner Research Institute,
9500 Euclid Avenue, Cleveland, Ohio 44195
Phone: (216) 444-5392
Fax: (216) 445-1466
Every living cell in our body is composed of hundreds of thousands of proteins. These proteins are highly coordinated in their functions for regulating diverse cellular processes and thus fundamental to our life. The broad theme of our research is to understand the molecular basis of some key protein-protein interactions in transducing cellular information (cell signaling) and their dysfunctions in human diseases such as heart failure, diabetes, and cancer. To this end, we have been focusing on a class of cell surface receptors, integrins, and their associated proteins. Integrins are major components of cell-extracellular matrix (ECM) adhesion, cell morphology, and cell motility. Using structural biology techniques, including NMR spectroscopy and crystallography, we aim to build a three dimensional atomic level landscape of integrin-mediated protein interaction network to gain thorough understanding of integrin signaling. Our work so far has significantly advanced the field by building key parts of this landscape, which provided important mechanistic insight into the mechanisms of integrin signaling. In collaboration with a group of cell biologists and clinical scientists, we also investigate other important cellular signaling pathways and their dysregulations. We have been able to link our recent atomic level findings to the pathogenesis of several human disorders with exciting identification of several potential protein inhibitors for these disorders. Our studies may ultimately help develop better approaches for diagnosing and treating the relevant human diseases.
Vinogradova, O., et al. A structural mechanism of integrin αIIbβ3 ‘inside-out’ activation as regulated by its cytoplasmic face. Cell, 110, 587-597, 2002.
Vaynberg, J. et al. Structure of an ultra weak protein-protein complex and its crucial role in regulation of cell morphology and motility. Molecular Cell, 17:513-523,2005.
Goksoy, E., et al. Structural basis for the autoinhibition of talin in regulating integrin activation. Molecular Cell,31:124-133, 2008.
Fukuda, K. et al. The pseudo active site of ILK is essential for its binding to a-parvin and localization to focal adhesions. Molecular Cell, 36:819-830, 2009.
Yang, J., et al. Structure of an integrin αIIbβ3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation. Proc. Natl. Acad. Sci. 106:17729-34, 2009.
Song X., et al. A novel membrane-dependent on/off switch mechanism of talin FERM domain at sites of cell adhesion. Cell Research 22:1533-45, 2012.
Integrin linked kinase (ILK) is a molecule that had long stumped researchers. While it was widely accepted that ILK plays an important role in cell adhesion, which is important for an array of physiological processes ranging from blood clotting to host immune defense, and that it is overexpressed in many diseases including cancer, diabetes and heart failure, the field was unclear on what ILK was. Some thought it was a kinase; some thought otherwise. For more than a decade, there was no definitive answer.
Pregnancy-induced hypertension, also known as preeclampsia, can be life-threatening for pregnant women and cause birth defects in children. Although the disease occurs in 8-10 percent of pregnancies, its cause and effective prevention remain elusive.
Jun Qin, PhD, Molecular Cardiology, has been named the Bonnie & Eunice Collins Endowed Chair for Innovative Diabetes Research.